Loading...

CytoDyn Inc.

CYDYPNK
Healthcare
Biotechnology
$0.29
$0.01(4.60%)

CytoDyn Inc. (CYDY) Stock Competitors & Peer Comparison

See (CYDY) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
CYDY$0.29+4.60%358.4M-14.32-$0.02N/A
NONOF$50.50-7.67%223.5B13.61$3.70+3.31%
CSLLY$87.21-1.85%168.4B31.85$2.73+1.52%
CMXHF$174.00+0.27%84.3B32.46$5.36+1.59%
UCBJF$219.79+0.73%42.3B34.60$6.44+0.71%
UCBJY$105.85-0.89%40.1B32.63$3.23+0.75%
ARGNF$547.60+0.00%33.5B33.45$16.37N/A
ODTC$22,005.00+29.44%24.1B1.07$20,580.00N/A
IVBXF$12.27+0.00%21B-1227.00-$0.01N/A
SBMFF$0.95+6.78%17B95.26$0.01+0.94%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

CYDY vs NONOF Comparison July 2025

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 358.4M. In comparison, NONOF has a market cap of 223.5B. Regarding current trading prices, CYDY is priced at $0.29, while NONOF trades at $50.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.32, whereas NONOF's P/E ratio is 13.61. In terms of profitability, CYDY's ROE is +0.07%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, CYDY is more volatile compared to NONOF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check NONOF's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;